These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Effect of streptokinase on reperfusion after acute myocardial infarction and its complications: an ex-post facto study. Taheri L, Boroujeni AZ, Kargar Jahromi M, Charkhandaz M, Hojat M. Glob J Health Sci; 2015 Jan 01; 7(4):184-9. PubMed ID: 25946921 [Abstract] [Full Text] [Related]
27. Streptokinase and enoxaparin in the pre-hospital management of the ST-segment elevation acute myocardial infarction. Tatu-Chiţoiu G, Oprişan M, Cismara O, Marinescu R, Marinescu A. Rom J Intern Med; 2002 Jan 01; 40(1-4):11-25. PubMed ID: 15526537 [Abstract] [Full Text] [Related]
28. Megadose heparin and streptokinase produce similar TIMI 3 flow at discharge in patients of acute myocardial infarction presenting between 7-12 hours. Dwivedi SK, Pramod K, Gupta R, Saran RK, Narain VS, Puri VK. Indian Heart J; 2000 Jan 01; 52(2):183-6. PubMed ID: 10893895 [Abstract] [Full Text] [Related]
29. [Clinical picture of acute myocardial infarction depending on the use of pharmacologic treatment schemes]. Jankowska A, Sarachman K, Drozd J, Palusiński R, Kudlicki J. Wiad Lek; 1995 Jan 01; 48(1-12):175-9. PubMed ID: 9638235 [Abstract] [Full Text] [Related]
31. Inhibitors of the kinin system as an alternative method of prevention or reduction reperfusive damages within thrombolytic therapy in patients with acute myocardium infarction. Korotkov A, Kistauri A, Korotkova A, Jibladze M, Guchua E. Georgian Med News; 2006 Nov 01; (140):54-62. PubMed ID: 17179590 [Abstract] [Full Text] [Related]
32. Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project. Huynh T, Cox JL, Massel D, Davies C, Hilbe J, Warnica W, Daly PA, FASTRAK II Network. Am Heart J; 2004 Jul 01; 148(1):86-91. PubMed ID: 15215796 [Abstract] [Full Text] [Related]
34. Excess heparin dosing among fibrinolytic-treated patients with ST-segment elevation myocardial infarction. Wang TY, Chen AY, Alexander KP, Ohman EM, Gibler WB, Peterson ED, Roe MT. Am J Med; 2008 Sep 01; 121(9):805-10. PubMed ID: 18724971 [Abstract] [Full Text] [Related]
35. [Death after ST-elevation myocardial infarction in patients treated with fibrinolytic therapy, angioplasty, or conventional therapy. A post-mortem study to verify cardiac rupture as a cause of death]. Fornaro G, Lazzero M, Giacalone A, Aralda D, Prando MD, Rossi L, Bongo AS. G Ital Cardiol (Rome); 2008 Jun 01; 9(6):408-20. PubMed ID: 18681392 [Abstract] [Full Text] [Related]
39. Double bolus of 0.75 MU streptokinase plus enoxaparin versus front-loaded alteplase plus unfractionated heparin in ST-segment elevation myocardial infarction. Tatu-Chiţoiu G, Teodorescu C, Dan M, Căpraru P, Guran M, Istrătescu O, Tatu-Chiţoiu A, Bumbu A, Dorobanţu M. Rom J Intern Med; 2003 Jul 25; 41(4):395-408. PubMed ID: 15526522 [Abstract] [Full Text] [Related]
40. [Influence of systemic arterial hypertension on mid-term survival of patients with acute myocardial infarction treated with fibrinolytic agents]. Martínez Sande JL, González-Juanatey JR, García-Acuña JM, Amaro Cendón A, Fernández Vázquez F, Fernández López JA, García Seara J, Vega Fernández JM, López Lago A, Gil de la Peña M. Med Clin (Barc); 1997 Oct 25; 109(14):532-7. PubMed ID: 9580043 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]